FDA-Inspected Site

Mclaughlin Gormley King Company

6 FDA inspections are on record for Mclaughlin Gormley King Company in Chaska, United States.

483· Form 483 issued

Chaska, United States · Last updated August 15, 2026

Overview

  • 6 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2021-12-08.

At a glance

Inspections

6

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
1 Dec 2021 – 8 Dec 2021Human Drugs483View 483 →
12 Nov 2015Human DrugsClean
30 Jul 2014Human DrugsClean
9 Nov 2009Not recordedClean
28 Jan 2008Not recordedClean
25 May 2006Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

8 Dec 2021
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Ross J Grigsby, Kevin P Regan

8 Dec 2021
21 CFR 211.80(a)

Written Procedures Not Followed

Cited by Ross J Grigsby, Kevin P Regan

Investigators

FDA investigators tied to this site in the record.

Courtney R Tiegs1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.80(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Mclaughlin Gormley King Company's 1 Form 483

Recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat